Tumor metastasis is the leading cause of death in cancer patients. It is the process by which a tumor cell leaves the primary tumor, disseminates to a distant site through the circulatory system and establishes a secondary tumor. 1 During the metastatic cascade, tumor cells must pass through the extracellular matrix barriers to accomplish the metastasis. Although the genetic basis of tumorigenesis can vary greatly, the steps required for metastasis are similar for all tumor cells. Therefore, interruption of metastasis is a promising approach to the treatment of cancers of various genetic origins. In our continuing search for anti-invasive compounds from microbial secondary metabolites, 2-5 rakicidin D (1) was isolated from the culture broth of an actinomycete strain of the genus Streptomyces. Rakicidins are the 15-membered depsipeptides consisting of three amino acids and a 3-hydroxyfatty acid (Figure 1 ). To date, three congeners, rakicidins A (2) and B (3) from Micromonospora and rakicidin C (4) from Streptomyces, have been reported. 6,7 Rakicidins contain a rare unusual amino acid, 4-amino-2,4-pentadienoate, which has been found only in the secondary metabolites from actinomycetes. Except for rakicidins, only two classes of cyclic peptides, BE43547 8 and vinylamycin, 9 are reported to date to contain this unusual amino acid. Herein, we describe the isolation, structure elucidation and biological properties of rakicidin D (1).
Tumor metastasis is the leading cause of death in cancer patients. It is the process by which a tumor cell leaves the primary tumor, disseminates to a distant site through the circulatory system and establishes a secondary tumor. 1 During the metastatic cascade, tumor cells must pass through the extracellular matrix barriers to accomplish the metastasis. Although the genetic basis of tumorigenesis can vary greatly, the steps required for metastasis are similar for all tumor cells. Therefore, interruption of metastasis is a promising approach to the treatment of cancers of various genetic origins. In our continuing search for anti-invasive compounds from microbial secondary metabolites, [2] [3] [4] [5] rakicidin D (1) was isolated from the culture broth of an actinomycete strain of the genus Streptomyces. Rakicidins are the 15-membered depsipeptides consisting of three amino acids and a 3-hydroxyfatty acid (Figure 1 ). To date, three congeners, rakicidins A (2) and B (3) from Micromonospora and rakicidin C (4) from Streptomyces, have been reported. 6, 7 Rakicidins contain a rare unusual amino acid, 4-amino-2,4-pentadienoate, which has been found only in the secondary metabolites from actinomycetes. Except for rakicidins, only two classes of cyclic peptides, BE43547 8 and vinylamycin, 9 are reported to date to contain this unusual amino acid. Herein, we describe the isolation, structure elucidation and biological properties of rakicidin D (1).
The producing strain Streptomyces sp. MWW064 was isolated from a marine sediment sample collected in Samut Sakhon province, Thailand. The strain was cultured in our standard medium for actinomycetes and the whole culture broth was extracted with 1-butanol. The extract showed inhibitory activity toward tumor cell invasion into Matrigel, the reconstituted extracellular matrix proteins. 10 Bioassay-guided fractionation of the extract led to the isolation of a new compound, rakicidin D (1).
Compound 1 was obtained as a colorless amorphous powder. The high-resolution ESITOFMS indicated a molecular formula of C 24 H 38 N 4 O 7 , which was consistent with the 1 H and 13 C NMR data. The IR spectrum of 1 indicated the presence of OH or NH (3356 cm À1 ) and carbonyl (1688 and 1648 cm À1 ) functionalities. The UV spectrum and the 1 H and 13 C NMR spectra of 1 showed high similarity to those for rakicidins A and B. 7 The 13 C NMR and HMQC analysis confirmed the presence of 24 carbons attributable to six deshielded signals including carbonyl carbons, two sp 2 methines, one sp 2 methylene, five sp 3 methines, six sp 3 methylenes, four methyl carbons and five exchangeable protons.
2-Amino-2,4-pentadienoate moiety was elucidated by a COSY correlation for H-9/H-10 and a series of HMBC correlations from H-12 to C-10 and C-11, from H-10 to C-8, C-11 and C-12, and from H-9 to C-8 and C-10 ( Figure 2 ). An NOE between H-10 and an exomethylene proton at d H 5.41 indicated that the latter proton and C-10 were located on the same side of the C-11/C-12 double bond. E configuration for the double bond between C-9 and C-10 was confirmed by a large coupling constant for H-9 and H-10 ( 3 J HH ¼15.0 Hz). HMBC correlations from H-7 to C-6 and C-8, and from H-6 to C-5 and C-8 established the connectivity of N-methylglycine and the pentadienoate. COSY correlations for 2-NH/H-2/H-3 and HMBC correlations from H-2 to C-1, H-3 to C-4 and 4-NH 2 to C-3 confirmed the presence of a b-hydroxyasparagine moiety. Connection of this amino acid to the glycine moiety was established by an HMBC correlation from 2-NH to C-5. Three additional fragments, H-23/H-14/H-15, H-24/H-16 and H-21/H-22, were recognized from the COSY spectrum. HMBC correlations from H-23 to C-13, C-14 and C-15, and from H-24 to C-15, C-16 and C-17, established the 2,4-dimethyl-3-hydroxyalkanoate substructure. Connectivity of this fragment to the peptide unit was elucidated by HMBC correlations from 11-NH to C-13 and from H-15 to C-1. Finally, the fragment C-22/C-21 containing the triplet methyl group, the methylene fragment C-20 that had an HMBC correlation from H-22 and the remaining two CH 2 fragments (C-18 and C-19) were assigned to the terminal linear moiety of the alkanoate to complete the planar structure of 1. Compound 1 has the same amino-acid components as rakicidins A and B but a shorter side chain with no terminal methyl branching in the fatty acid moiety.
Rakicidin D (1) inhibited the invasion of murine carcinoma colon 26-L5 cells with an IC 50 of 3.3 mg ml À1 (¼6.7 mM), whereas it showed no growth inhibition toward the same cell line at 10 mg ml À1 . 10 Rakicidins A (2) and B (3), which were separately obtained from Micromonospora sp. TP-A0860. Rakicidin B was described to have an isopropyl terminus in the fatty acid moiety but also described to have 3-hydroxy-2,4,16-trimethyloctadecanoic acid (anteiso-terminus), while the NMR data for rakicidin B were not provided in the literature. We thus reisolated rakicidin B and unambiguously confirmed that it had an iso-terminus on the basis of NMR analysis (see Supplementary Information). Compounds 2 and 3 showed much higher cytotoxicity toward the same cell line (IC 50 ¼0.44 mg ml À1 and 0.17 mg ml À1 ), giving a suggestion that the alkyl side chain of the fatty acid moiety has a key role in cytotoxic effect. Anti-invasive effects of 2 and 3 were not observed at noncytotoxic concentrations.
EXPERIMENTAL PROCEDURE General experimental procedure
Optical rotations were measured using a JASCO DIP-3000 polarimeter (JASCO, Tokyo, Japan). UV spectrum was recorded on a Hitachi U-3210 spectrophotometer (Hitachi, Ibaraki, Japan). IR spectrum was measured on a PerkinElmer Spectrum 100 (PerkinElmer, Waltham, MA, USA). NMR spectra were obtained on a Bruker AVANCE 400 or a Bruker AVANCE 500 spectrometer (Bruker, Bremen, Germany) in dimethyl sulfoxide-d 6 
Microorganism
Strain MWW064 was isolated from a sediment sample collected in Samut Sakhon province, Thailand. The strain was identified as a member of the genus Streptomyces on the basis of 99.0% 16S rRNA gene sequence (1431 nucleotides; DDBJ, DNA Data Bank of Japan, accession number GU295447) identity with Streptomyces argenteolus subsp. toyonakensis NBRC13847 (accession number AB184528.1).
Fermentation
Strain MWW064 cultured on a slant agar medium was inoculated into 500-ml K-1 flasks each containing 100 ml of the V-22 seed medium consisting of soluble starch 1%, glucose 0.5%, NZ-case 0.3%, yeast extract 0.2%, triptone (Difco Laboratories, Sparks, MD, USA) 0.5%, K 2 HPO 4 0.1%, MgSO 4 Á7H 2 O 0.05% and CaCO 3 0.3% (pH 7.0). The flasks were cultivated on a rotary shaker (200 r.p.m.) at 30 1C for 4 days. The seed culture (3 ml) was transferred into 500-ml K-1 flasks each containing 100 ml of the A-3M production medium consisting of glucose 0.5%, glycerol 2%, soluble starch 2%, Pharmamedia (Traders Protein, Memphis, TN, USA) 1.5%, yeast extract 0.3% and Diaion HP-20 (Mitsubishi Chemical, Kanagawa, Japan) 1%. The pH of the medium was adjusted to 7.0 before sterilization. The inoculated flasks were cultured on a rotary shaker (200 r.p.m.) at 30 1C for 6 days.
Extraction and isolation
At the end of the fermentation period, 50 ml of 1-butanol was added to each flask, and they were allowed to shake for 1 additional hour. The mixture was centrifuged at 6000 r.p.m. for 10 min and the organic layer was separated from the aqueous layer containing the mycelium. Evaporation of the solvent gave 27.9 g of crude extract from 3 liter of culture. The crude extract (27.9 g) was subjected to silica gel column chromatography with a step gradient of 
